AnalystBook Research · Company Intelligence

MEDICINOVA INC

MNOVNasdaq

Built from MEDICINOVA INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score -18.48 distress zone — historically elevated failure riskWatch

Where the revenue comes from

Fiscal 2025, as MEDICINOVA INC reports it. History and quarterly detail are in the app.

  • Reportable Segment Aggregation Before Other Operating$410K

Leadership changes

From MEDICINOVA INC's own filings, the day they're filed.

  • Geoffrey O'Brien · President · departureeff. 2024-04-02
  • Nicole Lemerond · director · appointmenteff. 2023-08-04

Latest filings

  • 8-K · Company announcement2026-09-02
  • 8-K · Company announcement2026-08-19
  • 10-Q · Quarterly report2026-08-13
  • 8-K · Company announcement2026-06-24
  • 10-Q · Quarterly report2026-05-14
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about MEDICINOVA INC, every answer cited to the official filings🔒
  • The Intelligence Brief — added when MEDICINOVA INC's brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.